UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing

Genetics in medicine, 2015-07, Vol.17 (7), p.587-595

2015

Volltextzugriff (PDF)

Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2084-2091

2015

Volltextzugriff (PDF)

Covasim: An agent-based model of COVID-19 dynamics and interventions

PLoS computational biology, 2021-07, Vol.17 (7), p.e1009149

2021

Volltextzugriff (PDF)

Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure

Health affairs (Millwood, Va.), 2016-05, Vol.35 (5), p.805

2016

Volltextzugriff (PDF)

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study

Cancer medicine (Malden, MA), 2018-09, Vol.7 (9), p.4251-4260

2018

Volltextzugriff (PDF)

RE: “TRANSPORTABILITY OF TRIAL RESULTS USING INVERSE ODDS OF SAMPLING WEIGHTS”

American journal of epidemiology, 2018-12, Vol.187 (12), p.2716-2717

2018

Volltextzugriff (PDF)

Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials

JNCI : Journal of the National Cancer Institute, 2016-02, Vol.108 (2), p.djv324

2016

Volltextzugriff (PDF)

Do cancer treatments have option value? Real‐world evidence from metastatic melanoma

Health economics, 2019-07, Vol.28 (7), p.855-867

2019

Volltextzugriff (PDF)

Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC

Advances in therapy, 2021-04, Vol.38 (4), p.1843-1859

2021

Volltextzugriff (PDF)

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation

Journal of genetic counseling, 2019-04, Vol.28 (2), p.477

2019

Volltextzugriff (PDF)

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation

Journal of genetic counseling, 2019-04, Vol.28 (2), p.477-490

2019

Volltextzugriff (PDF)

Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group

Medical decision making, 2016-07, Vol.36 (5), p.641-651

2016

Volltextzugriff (PDF)

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

PharmacoEconomics, 2020-02, Vol.38 (2), p.171-179

2020

Volltextzugriff (PDF)

Response to Phillips et al

Genetics in medicine, 2015-04, Vol.17 (4), p.315-315

2015

Volltextzugriff (PDF)

Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer

Medical care, 2016-07, Vol.54 (7), p.719-724

2016

Volltextzugriff (PDF)

Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study

Contemporary clinical trials, 2019-09, Vol.84, p.105820-105820, Article 105820

2019

Volltextzugriff (PDF)

Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes

Contemporary clinical trials, 2014-09, Vol.39 (1), p.1-8

2014

Volltextzugriff (PDF)

Abstract A81: Relationship between out-of-pocket cost and use of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

Cancer epidemiology, biomarkers & prevention, 2016-03, Vol.25 (3_Supplement), p.A81-A81

2016

Volltextzugriff (PDF)

Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials

JNCI : Journal of the National Cancer Institute, 2016-02, Vol.108 (2), p.1

2016

Volltextzugriff (PDF)

Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion

NBER Working Paper Series, 2017-09, p.23842

2017

Volltextzugriff (PDF)

Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents

BMC medical research methodology, 2012-02, Vol.12 (1), p.21-21, Article 21

2012

Volltextzugriff (PDF)

Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial

European urology, 2012-08, Vol.62 (2), p.204-209

2012

Volltextzugriff (PDF)

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

BMJ (Online), 2013-04, Vol.346, p.f2023

2013

Volltextzugriff (PDF)

Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications

Medical decision making, 2023-04, Vol.43 (3), p.275-287

2023

Volltextzugriff (PDF)

Racial disparities in access to prostate cancer clinical trials: A county-level analysis

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6553-6553

2021

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(41)
Dissertationen
(1)

Sprache

Englisch
(42)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing

Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis

Covasim: An agent-based model of COVID-19 dynamics and interventions

Steady Increase In Prices For Oral Anticancer Drugs After Market Launch Suggests A Lack Of Competitive Pressure

Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study

RE: “TRANSPORTABILITY OF TRIAL RESULTS USING INVERSE ODDS OF SAMPLING WEIGHTS”

Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials

Do cancer treatments have option value? Real‐world evidence from metastatic melanoma

Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation

Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group

Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment

Response to Phillips et al

Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer

Clinical exome sequencing vs. usual care for hereditary colorectal cancer diagnosis: A pilot comparative effectiveness study

Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes

Abstract A81: Relationship between out-of-pocket cost and use of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia

Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials

Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion

Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents

Individualized Estimation of the Benefit of Radical Prostatectomy from the Scandinavian Prostate Cancer Group Randomized Trial

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

Mimicking Clinical Trials Using Real-World Data: A Novel Method and Applications

Racial disparities in access to prostate cancer clinical trials: A county-level analysis

Suchergebnisse filtern